Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.

David Haigh, E.M. Amphlett, G.S. Bravi, H. Bright, V. Chung, C.L. Chambers, A.G. Cheasty, M.A. Convery, M.R. Ellis, R. Fenwick, D.F. Gray, C.D. Hartley, P.D. Howes, R.L. Jarvest, K.J. Medhurst, A. Mehbob, D. Mesogiti, F. Mirzai, F. Nerozzi, N.R. ParryN. Roughley, T. Skarzynski, M.J. Slater, S.A. Smith, R. Stocker, C.J. Theobald, P.J. Thomas, P.A. Thommes, J.H. Thorpe, C.S. Wilkinson, E. Williams

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.'. Together they form a unique fingerprint.

Engineering & Materials Science

Chemical Compounds